SCOTTS COMPANY
SC 13D/A, 1999-11-17
AGRICULTURAL CHEMICALS
Previous: PUTNAM VARIABLE TRUST, 485APOS, 1999-11-17
Next: VANGUARD EQUITY INCOME FUND INC, N-30D, 1999-11-17



                                                                   ------------
                                                                   OMB APPROVAL
                                                                   ------------
                        -------------------------------
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                             ----------------------
                                  SCHEDULE 13D
                                 (Rule 13d-101)

            INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
           TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
                                  RULE 13d-2(a)
                   UNDER THE SECURITIES EXCHANGE ACT OF 1934

                               (Amendment No. 2)1

                               The Scotts Company
- --------------------------------------------------------------------------------
                                (Name of Issuer)

                        Common Shares, without par value
- --------------------------------------------------------------------------------
                         (Title of Class of Securities)

                                  810 186 106
- --------------------------------------------------------------------------------
                                 (CUSIP Number)

                                 James Hagedorn
                          800 Port Washington Boulevard
                            Port Washington, NY 11050
                                 (516) 883-6550

                                 with a copy to:

                               Richard L. Goldberg
                               Proskauer Rose LLP
                                  1585 Broadway
                               New York, NY 10036
- -------------------------------------------------------------------------------
            (Name, Address and Telephone Number of Person Authorized
                     to Receive Notices and Communications)


                                 October 4, 1999
- --------------------------------------------------------------------------------
             (Date of Event which Requires Filing of this Statement)

     If the filing  person has  previously  filed a statement on Schedule 13G to
report the  acquisition  that is the subject of this Schedule 13D, and is filing
this  schedule  because  of Rule  13d-1(e),  13d-1(f)  or  13d-1(g),  check  the
following box |_|.

     Note:  Schedules  filed in paper format shall include a signed original and
five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.



1 The remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for any  subsequent  amendment  containing  information  which  would  alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).

                                  Page 1 of 6
<PAGE>

CUSIP No. 810 186 106                  SCHEDULE 13D           Page 2 of 6 Pages


________________________________________________________________________________
1    NAME OF REPORTING PERSONS

     Hagedorn Partnership, L.P.

     I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS: EIN 11-3265232
________________________________________________________________________________
2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
                                                                 (a)  [_]
                                                                 (b)  [_]
________________________________________________________________________________
3    SEC USE ONLY

________________________________________________________________________________
4    SOURCE OF FUNDS*: 00


________________________________________________________________________________
5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
     PURSUANT TO ITEMS 2(d) OR 2(e)                                   [_]

________________________________________________________________________________
6    CITIZENSHIP OR PLACE OF ORGANIZATION:  Delaware

________________________________________________________________________________
               7    SOLE VOTING POWER

  NUMBER OF         13,067,578

   SHARES      _________________________________________________________________
               8    SHARED VOTING POWER
BENEFICIALLY
                    -0-
  OWNED BY
               _________________________________________________________________
    EACH       9    SOLE DISPOSITIVE POWER

  REPORTING         12,802,989

   PERSON      _________________________________________________________________
               10   SHARED DISPOSITIVE POWER
    WITH
                    264,589

________________________________________________________________________________
11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

13,067,578
________________________________________________________________________________
12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

                                                                      [_]

________________________________________________________________________________
13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     41.6%

________________________________________________________________________________
14   TYPE OF REPORTING PERSON*: PN


________________________________________________________________________________
                     *SEE INSTRUCTIONS BEFORE FILLING OUT!


<PAGE>


     By this  Amendment No. 2, Hagedorn  Partnership,  L.P. (the  "Partnership")
further  amends and  supplements  its  Statement on Schedule  13D, as heretofore
amended (the "Schedule 13D"),  filed with respect to the common shares,  without
par value (the "Shares"), of The Scotts Company, an Ohio corporation ("Scotts").
Capitalized  terms not  otherwise  defined  have the  meanings  set forth in the
Schedule 13D.

Item 1. Security of Issuer

     The current  address of the  principal  executive  officers of Scotts is 41
South High Street, Suite 3500, Columbus, Ohio 43215.

Item 2. Identity and Background

     (a)-(c)  Attached  as  Schedule  I to  this  Amendment  No.  2  is  updated
information as to the present  principal  occupation or employment and the name,
principal business and address of any corporation or other organization in which
such employment is conducted, of each General Partner.

Item 3. Source and Amount of Funds or Other Consideration

     Pursuant to the First  Amendment to the Amended and Restated  Agreement and
Plan of  Merger,  dated as of October 1, 1999 (the  "First  Amendment"),  by and
among Scotts,  Scotts'  Miracle-Gro  Products,  Inc.,  Miracle-Gro Lawn Products
Inc.,  Miracle-Gro  Products Limited,  the Partnership,  Community Funds,  Inc.,
Horace Hagedorn, John Kenlon, and the General Partners ("First Amendment"),  the
Partnership  converted all of the 187,523 shares of Preferred Stock owned by the
Partnership  into 9,869,631 Shares in accordance with the terms of the Preferred
Stock and without any cash payment by the Partnership.

     The  Partnership  also  received  from  Scotts (in  addition to the regular
quarterly cash dividend on the Preferred  Stock for the quarter ended  September
30, 1999) a cash payment of $6,250,766.67,  representing the aggregate amount of
the  dividends  that would have  accrued and been  payable on the  Partnership's
187,523  shares of Preferred  Stock with respect to the period from October 1999
through May 2000,  the first month during which the  Preferred  Stock would have
become  redeemable by Scotts.  The other holders of the  Preferred  Stock,  John
Kenlon and Horace  Hagedorn,  also converted their shares of Preferred Stock and
received cash payments in lieu of dividends pursuant to the First Amendment.

     Under the First  Amendment,  all of the provisions of the Merger  Agreement
described in the Schedule 13D in response to Item 6 relating to the acquisition,
voting and  disposition of securities of Scotts by the Partnership and the other
Miracle-Gro Shareholders, the right of the Miracle-Gro Shareholders to designate
three members of the Scotts Board of Directors, and the need for approval by the
Miracle-Gro  shareholders for certain stock issuances or acquisitions by Scotts,
were  terminated  as of  October  1,  1999,  except  the  restriction  upon  the
acquisition by the Miracle-Gro Shareholders of more than 49% of the total voting
power of the  outstanding  Voting Stock.  The provisions  that  terminated as of
October 1, 1999 would  otherwise  have  terminated  on May 19,  2000,  the fifth
anniversary of the consummation of the Merger Agreement.

Item 4. Purpose of the Transaction

     The Partnership agreed to enter into the First Amendment and consummate the
transactions contemplated thereby because it believed that the conversion of the
outstanding  shares of Preferred  Stock into Shares on the terms provided for in
the First Amendment was in the best interests of Scotts, the Partnership and the
other  shareholders of Scotts.  Neither the Partnership nor the General Partners
have any


                                    Page 3 of 6

<PAGE>



plans or proposals that relate to or would result in any of the consequences set
forth in Items  4(a)-(j)  of Schedule  13D.  The  Partnership  intends to review
continuously  its position in Scotts,  and may, at any time,  depending upon its
evaluation of Scotts'  business and  prospects,  other  developments  concerning
Scotts  (including,  without  limitation,  any future  repurchases  of Shares by
Scotts), general economic conditions,  stock market conditions and the financial
needs and  objectives of the  Partnership,  increase or decrease its holdings of
Scotts  securities  or dispose of such  holdings in their  entirety,  whether in
transactions  in the open market or otherwise,  or otherwise act with respect to
Scotts.

Item 5. Interest in Securities of the Issuer

     (a) As a result of the  conversion of the  outstanding  shares of Preferred
Stock pursuant to the First Amendment, the Partnership owns 9,869,631 Shares and
holds Warrants to purchase an additional  2,933,358 Shares. The Partnership also
has the right to vote, and a right of first refusal with respect to, the 197,947
Shares and the Warrants to purchase  66,642  Shares owned by Mr.  Kenlon and his
children.  In the aggregate,  the outstanding Shares held by the Partnership and
Mr. Kenlon and the aggregate  number of Warrants  held by the  Partnership,  Mr.
Kenlon and his children represent approximately 41.6% of the outstanding Shares,
calculated in accordance with Rule 13d-3 based on the 18,357,302 Shares reported
as being  outstanding  in  Scotts'  Quarterly  Report on Form 10-Q in the fiscal
quarter  ended  July 3, 1999.  Except to the  extent  they may be deemed to have
beneficial ownership of the Scotts securities owned by the Partnership,  none of
the General Partners  beneficially  owns any Scotts  securities other than James
Hagedorn,  who owns 3,370 Shares  beneficially  and of record,  holds options to
purchase an additional  150,000 Shares that are either currently  exercisable or
will become exercisable within 60 days, and has 8,074.073 Shares credited to his
account,  as of September 30, 1999, under The Scotts Company  Retirement Savings
Plan (the "401(k) Plan").

     (b) The Partnership has the sole power to vote all of the Scotts securities
held  by it and by Mr.  Kenlon  and  his  children.  The  Partnership  has  sole
dispositive  power with  respect to the Scotts  securities  held by it,  and, by
virtue of its right of first refusal,  may be deemed to have shared  dispositive
power with respect to the Scotts securities held by Mr. Kenlon and his children.
James Hagedorn has sole voting and dispositive  power with respect to the Scotts
securities described in the preceeding paragraph as being owned by him, subject,
with respect to the  8,074.073  Shares  credited to his account under the 401(k)
Plan, to the terms of such Plan.

     (c) The Partnership  converted 3,135 shares of Preferred Stock into 164,995
Shares on August 30, 1999, and sold such Shares on August 31, 1999 in accordance
with Rule 144 promulgated under the Securities Act of 1933. The net proceeds per
Share to the Partnership from such sale was $38.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to
Securities of the Issuer.

     See the response to Items 2, 3 and 5 set forth in this Amendment No. 2.

Item 7. Material to Be Filed as Exhibits

     The  following  additional  exhibit is added as Exhibit (c) to the Schedule
13D:




                                    Page 4 of 6

<PAGE>


     Exhibit (c)    First  Amendment to Amended and Restated  Agreement and Plan
                    of Merger,  made and entered into as of October 1, 1999,  by
                    and among The Scotts Company,  Scotts' Miracle-Gro Products,
                    Inc.,  Miracle-Gro Lawn Products Inc.,  Miracle-Gro Products
                    Limited, Hagedorn Partnership,  L.P., Community Funds, Inc.,
                    Horace Hagedorn, John Kenlon, and James Hagedorn,  Katherine
                    Hagedorn Littlefield,  Paul Hagedorn, Peter Hagedorn, Robert
                    Hagedorn and Susan  Hagedorn  (Incorporated  by reference to
                    Exhibit 2 to The Scotts Company's Current Report on Form 8-K
                    dated October 4, 1999).

Signature

     After  reasonable  inquiry and to the best of my  knowledge  and belief,  I
certify that the information  set forth in this statement is true,  complete and
correct.


October 29, 1999                          HAGEDORN PARTNERSHIP, L.P.


                                          By: /s/ Katherine Hagedorn Littlefield
                                              ----------------------------------
                                              Name:
                                              Title:  General Partner


                                   Page 5 of 6

<PAGE>

                                   Schedule I


General Partners of
Hagedorn Partnership, L.P.

     The name, business address, present principal occupation or employment, and
the name,  principal business (other than in the case of The Scotts Company) and
address of any  corporation or other  organization  in which such  employment is
conducted,  of each general partner of the Partnership is set forth below. If no
address is given, the address is 800 Port Washington Boulevard, Port Washington,
New York 11050.

                                            Present Principal Occupation
                                            or Employment and
Name                                        Business Address
- ------------------------                    --------------------------------
James Hagedorn                              President, Scotts North America
                                            The Scotts Company

Katherine Hagedorn Littlefield              Private Investor

Paul Hagedorn                               Creative Consultant,
                                            The Scotts Company
                                            14111 Scottslawn Road
                                            Marysville, OH 43041

Peter Hagedorn                              Private Investor

Robert Hagedorn                             Private Investor

Susan Hagedorn, Ph.D.                       Professor of Nursing,
                                            University of Colorado Hospital
                                            (School of Nursing)
                                            Box C-288
                                            4200 East 9th Avenue
                                            Denver, CO 80262




                                    Page 6 of 6


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission